METHOD FOR EVALUATING A SCORE REPRESENTING THE HEALTH OF A PATIENT AND PRODUCTS IMPROVING THE SCORE

Abstract

A method for determining a numerical score representative of a patient's health, is characterized by the following steps. At an initial calibration step, a database is established from a series of indicators relating to the state of health of the patient, each indicator being assigned a numerical value, and afterwards a statistical analysis of this database is performed so as to establish for each of said indicators a score depending on a measured value of the indicators of the state of health with respect to reference values, and to establish at least four groups constituted by said indicators, each of said groups representing information corresponding respectively to oxidative stress, hereinafter Group 1; to functions of the digestive brain, hereinafter Group 2; to functions of the reptilian brain, hereinafter Group 3; and to physical abilities of the patient coupled to his information on his general state of health, hereinafter Group 4. Furthermore, a value is assigned to each group, then a health score S specific to the patient is calculated using the formula:

S=(Value Group 1+(2* Value Group 2)+(2* Value Group 3)+(3* Value Group 4))/(2* Number of groups)

Claims

1. A method for determining a numerical score representative of a patient's health, characterized by the following steps: at an initial calibration step, a database is established from a series of indicators relating to the state of health of the patient, each indicator being assigned a numerical value, comprised between 0 and 10, and afterwards a statistical analysis of this database is performed so as to: establish for each of said indicators a score, comprised for example between 1 and 10, depending on a measured value of the indicators of the state of health with respect to reference values, establish at least four groups constituted by said indicators, each of said groups representing information corresponding respectively: to oxidative stress, hereinafter Group 1; to functions of the digestive brain, hereinafter Group 2; to functions of the reptilian brain, hereinafter Group 3; and to physical abilities of the patient coupled to his information on his general state of health, hereinafter Group 4, and a value is assigned to each group, comprised between 0 and 100, the value of each group being derived from the results of each indicator, then a health score S specific to the patient is calculated using the formula:
S=Σ(Value Group 1+(2* Value Group 2)+(2* Value Group 3)+(3* Value Group 4))/(2* Number of groups)

2. The method according to claim 1, characterized in that the numerical score is determined on a scale of 0 to 100.

3. The method according to claim 1, characterized in that the value of Group 1 is determined using scores relating to a digestive analysis, an oxidized LDL (Low Density Lipoprotein) value, a HOMA (homoestasis model assessment) index, a Selenium value, a Ferritin value, and a Zinc value.

4. The method according to claim 1, characterized in that the value of Group 2 is determined using scores relating to a digestive analysis, a CRP (C-reactive protein) value, a HOMA index and a value of the ratio Omega 6/Omega 3.

5. The method according to claim 1, characterized in that the value of Group 3 is determined using scores relating to a health questionnaire, a value relating to the measurement of the perception time, an homocysteine value, a value of the Omega 3 index, a score relating to cardiac variability parameters at night in particular, a value of the root mean square of the successive differences of the heart rate, a value of the LF/HF (low frequency/high frequency) ratio reflecting the sympathico-vagal overall balance, a value of the recovery index during sleep, and a value relating to measurements performed on the total activity of the autonomous nervous system.

6. The method according to claim 1, characterized in that the value of Group 4 is determined in particular using scores relating to a health questionnaire, to a cardiac stress test in terms of speed or power, to the measurement of the heartbeat amplitude, to a score relating to a speed test at a value of the root mean square of successive differences of the heart rate equal or lower than 10, to a somesthetic test, a visual test, a vestibular test, a ferritin value, a HOMA index, a Zinc value, a selenium value, a CRP value and a value of an immunity questionnaire.

7. The method according to claim 1, characterized in that values comprised between 0 and 10 are assigned to each indicator.

8. The method according to claim 1, characterized in that besides the tests composing groups 1 to 4, calculation of the health score S takes into account two additional tests in the form of an urinalysis and a genetic test allowing drawing up an assessment covering toxic metals, such as mercury, arsenic or lead.

9. A product for its therapeutic use by improving the state of health according to a score obtained by the method according to claim 1, the product including between 1L and 3L of water, between 100 mL and 300 mL of lemon juice, between 100 mL and 300 mL of maple syrup, between 3 g and 200 g of ginger, between 1 g and 50 g of paprika and between 1 g and 30 g of butyric acid.

10. A product for its therapeutic use by improving state of health according to a score obtained by the method of claim 1, by acting in particular on the detected heavy metals, the product including between 5 g and 50 g of Chlorella, between 1 g and 20 g of Coriander and between 1 g and 20 g of Allium ursinum (bear's garlic).

11. The product according to claim 9, intended to be administered on an empty stomach for 2 to 6 days.

12. A product for its therapeutic use by improving the state of health according to a score obtained by the method of claim 1, the product including either: a. Between 300 mg and 800 mg of N-acetyl-cysteine, between 4 mg and 30 mg of Zincii (citras), between 10 mcg and 120 mcg of Selenium and between 10001 and 50001 of Chlocalciferolum D3; or b. Between 50 mcg and 400 mcg of Acidum folicum, between 0.1 mg and 5 mg of Methylcobalaminum, between 50 mg and 300 mg of S-adenosyl-L-methionine, and between 50 mg and 600 mg of Magnesii citras; or c. Between 10 mg and 400 mg of Resveratrolum, between 10 mg and 400 mg of Trigonella foenum graecum extractum siccum, between 10 mg and 400 mg of Acidum alginicum and between 10 mg and 400 mg of Lycopenum.

13. A product for its therapeutic use by improving the state of health according to a score obtained by the method of claim 1, the product in the form of biscuit including between 1 g and 30 g of blond Psyllium and between 1 g and 30 g of oat bran.

14. A product for its therapeutic use by improving the state of health according to a score obtained by the method of claim 1, by acting in particular on detected heavy metals, the product in the form of biscuit including between 40% and 55% of oat bran, between 10% and 20% of apple Pectin, between 10% and 20% of Chlorella and between 10% and 20% of blond Psyllium.

Description

[0031] The features of the invention will appear more clearly upon reading several embodiments given only as non-limiting examples, with reference to the schematic drawing, wherein:

[0032] FIG. 1 is a diagram of the interaction between the encephalic brain and the digestive brain.

[0033] FIG. 1 illustrates the interaction between the encephalic brain 1 and the digestive brain 2. The encephalic brain 1 is composed of a brain called reptilian brain 11, which is the most important area of the encephalic brain 1 as regards health, and other areas 12 which have regulatory actions on the reptilian brain 11.

[0034] The digestive brain 2 must ensure energy supplies, essential nutrients, vitamins and trace elements. It must also act as a protective barrier in order to prevent the inlet of undesired intruders. The digestive brain 2 permanently communicates with the encephalic brain 1 via the enteric nervous system and by numerous hormones, lipoproteins, interleukins and other substances.

[0035] In order to improve our state of health, one must ensure a proper operation of the four immune barriers 3, namely the intestinal mucosa 34, the skin 32, the pulmonary mucosa 33 and the blood—brain barrier 31.

[0036] The four immune barriers 3 protect the encephalic brain 1. Moreover, one must also ensure the quality and the quantity of the nutritional supplies essential to the organism, the optimal activation of the encephalic 1 and reptilian 11 brains and finally an optimal operation of the higher centers of the brain for the regularization of the reptilian brain 11.

[0037] The encephalic brain 1 is the motor, regulator and coordinator of all the essential functions. For the encephalic brain 1 to operate well, it must on the one hand be protected by the digestive brain 2, and on the other hand it must be permanently activated. Physical activity, movement through the stimulation of the neurons of the cerebellum, is the most important activation. The other visual, auditory, gustatory and tactile stimulations also play this role.

[0038] For each patient, a complete functional assessment of both brains 1, 2 and of oxidative stress factors is performed in order to accurately determine a score of the state of health and of the individual objectives.

[0039] In order to determine the health score of a patient, the patient must undergo a series of tests, questionnaires which will allow determining a value to each indicator.

[0040] Thus, firstly, an establishment of the history of symptoms specific to the two brains 1, 2 allows quantifying and classifying dysfunctions according to their significance. A complementary questionnaire allows getting to know the dietary habits.

[0041] Afterwards, a clinical examination focused on an in-depth functional neurology examination allows determining the operation level of the reptilian brain 11 as well as the control capacity of the higher cortical areas.

[0042] In particular, the individual operation and the interaction of the three main sensory systems, namely the peripheral, vestibular and ocular systems, are assessed. The adaptation of the motor system, the visual capabilities when the head is moving and the functional capabilities of the joints of the lower limbs are also assessed.

[0043] Next, an examination of the locomotion functions and physical abilities allows determining the intensity of the physical activity which will be the most beneficial and the progress margin.

[0044] At a next step, a measurement of the bioimpedance determines the electrical resistance and the reactance of our body. These two values are important to monitor the evolution of the health of the patient. The estimates of the total body water, of the intra- and extra-cellular water are also important in the context of an individualized follow-up.

[0045] At one step, a micro-nutritional assessment comprises a specific blood panel allowing assessing the current oxidative stress, the capacities to deal with it, as well as the antecedent lesions that it has caused. This micro-nutritional assessment also comprises an assessment of fatty acids, a measurement of the digestive inflammation, if necessary a measurement of the intestinal permeability and finally a measurement of the capacity to produce energy and of the permeability of the blood-brain barrier.

[0046] Afterwards, the cardiac variability during effort and for 24h must be determined by a measurement of the activity of the reptilian brain through the cardiac variability during effort and for 24h. This test also allows to measure the sleep quality and the individual capacity to recover.

[0047] Finally, a step of measuring the force of the inspiratory muscles allows to assess the operation of the thoracic cage as well as the presence of metaboreflex, which is an important sign of hyperactivity of the sympathetic system.

[0048] Once all of these steps are carried out, the measured values of the indicators allow establishment for each of said indicators, a score depending on the measured value with respect to reference values.

[0049] A value is assigned to each of the four groups constituted by said indicators, each of said groups representing information corresponding respectively to the oxidative stress, hereinafter Group 1; to the functions of the digestive brain, hereinafter Group 2; to the functions of the reptilian brain, hereinafter Group 3; and to the physical abilities of the patient coupled to his information on his general state of health, hereinafter Group 4.

[0050] Finally, a health score S specific to the patient is calculated, on a scale ranging from 0 to 100, using the formula:

S=(Value Group 1+(2* Value Group 2)+(2* Value Group 3)+(3* Value Group 4))/(2* Number of groups)

[0051] For example, a patient whose value of group 1 is 49.17, value of group 2 is 47.27, value of group 3 is 86.92 and value of group 4 is 99.12 would have a health score S=76.86.

[0052] In this example, the closer the value of the health score is to the value 100, the more the patient is in good health.

[0053] In order to improve this score, the patient can take a drink including for example 2L of water, 150 mL of lemon juice, 150 mL of maple syrup, 2 g of ginger, 1 g of paprika and 10 g of butyric acid.

[0054] This drink can be administered exclusively (on an empty stomach) for a period of 4 days for example.

[0055] If the patient has performed the two additional tests in the form of an urinalysis and of a genetic test allowing drawing up an assessment covering toxic metals, such as mercury, arsenic or lead so as to improve the health score of the patient, depending on the measured results, he can ingest, on a daily basis, a product to improve the result, the product including for example 25 g of chlorella, 5 g of coriander, and 5 g of allium ursinum (bear's garlic). This product may also be ingested for about 4 days.

[0056] Still to improve the measured health score, the patient can ingest, in the form of pills, a product including 600 mg of N-acetylcysteine, 12 mg of Zincii (citras), 50 mcg of Selenium, 300UI of Chlocalciferolum D3.

[0057] In the same manner, to improve the measured health score, the patient can ingest, in the form of pills, a product including 200 mcg of acidum folicum, 1 mg of methylcobalaminum, 100 mg of S-adenosyl-L-methionine and 250 mg of magnesii citras.

[0058] In order to improve the measured health score, the patient can ingest, in the form of pills, another product including 100 mg of Resveratrolum, 250 mg of Trigonella foenum graecum extractum siccum, 250 mg of Acidum alginicum, and 250 mg of Lycopenum.

[0059] In the long run and in order to stabilize achievements having allowed reaching a better result, a product in the form of biscuit including 5 g of blond psyllium and 5 g of oat bran may be ingested every day.

[0060] In order to tackle heavy metals over time, another product in the form of a biscuit may be ingested by the patient, the biscuit including 50% of oat bran, 16.6% of apple pectin, 16.6% of Chlorella and 16.6% of blond Psyllium.

[0061] For example, a four-month period allows establishing significant changes having a real impact on health. It is only at the end of that period that the improvement of the blood panel and of the sleep quality will be visible, as best indicator of the function of the reptilian brain of the patient. The comparative analysis of the assessments before and after the program will demonstrate the improvement on the health score of the patient.